| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.8 |